قصور القلب مع المحافظة على الجزء المقذوف
مراجع

↑  Disease Ontology (بالإنجليزية), 27 May 2016, QID:Q5282129
↑  Owan TE، Hodge DO، Herges RM، Jacobsen SJ، Roger VL، Redfield MM (2006). "Trends in prevalence and outcome of heart failure with preserved ejection fraction". نيو إنغلاند جورنال أوف ميديسين. ج. 355 ع. 3: 251–59. DOI:10.1056/nejmoa052256. PMID:16855265. مؤرشف من الأصل في 2018-10-31. نسخة محفوظة 31 أكتوبر 2018 على موقع واي باك مشين.
1 2 3 4 5  Hurst 2001.
↑  Redfield، Margaret (10 نوفمبر 2016). "Heart Failure with Preserved Ejection Fraction". New England Journal of Medicine. ج. 375 ع. 19: 1868–77. DOI:10.1056/NEJMcp1511175. PMC:4075067.
↑  "Heart failure with preserved ejection fraction: is this diastolic heart failure?". مؤرشف من الأصل في 2011-08-17. اطلع عليه بتاريخ 2012-02-16.
↑  Zakeri, R., Chamberlain, A. M., Roger, V. L., & Redfield, M. M. (2013). Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study. Circulation, CIRCULATIONAHA-113.
↑  Witteles, R. M. and Fowler, M. B. (2008). Insulin-Resistant Cardiomyopathy. Clinical Evidence, Mechanisms, and Treatment Options. Journal of the American College of Cardiology, 51(2):93–102.
↑  Lim, Gregory B. "Macrophages promote cardiac fibrosis and diastolic dysfunction." (2018).
↑  Hulsmans, Maarten; Sager, Hendrik B.; Roh, Jason D.; Valero-Muñoz, María; Houstis, Nicholas E.; Iwamoto, Yoshiko; Sun, Yuan; Wilson, Richard M.; Wojtkiewicz, Gregory (5 Feb 2018). "Cardiac macrophages promote diastolic dysfunction". Journal of Experimental Medicine (بالإنجليزية). 215 (2): 423–440. DOI:10.1084/jem.20171274. ISSN:0022-1007. PMID:29339450. Archived from the original on 2019-06-10.
↑  Mohammed, S. F., Majure, D. T., & Redfield, M. M. (2016). Zooming in on the Microvasculature in Heart Failure With Preserved Ejection Fraction.
↑  González-López E، Gallego-Delgado M، Guzzo-Merello G، de Haro-Del Moral FJ، Cobo-Marcos M، Robles C، Bornstein B، Salas C، Lara-Pezzi E، Alonso-Pulpon L، Garcia-Pavia P (7 أكتوبر 2015). "Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction". Eur Heart J. ج. 36 ع. 38: 2585–94. DOI:10.1093/eurheartj/ehv338. PMID:26224076.
↑  Mohammed SF، Mirzoyev SA، Edwards WD، Dogan A، Grogan DR، Dunlay SM، Roger VL، Gertz MA، Dispenzieri A، Zeldenrust SR، Redfield MM (أبريل 2014). "Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction". JACC Heart Fail. ج. 2 ع. 2: 113–22. DOI:10.1016/j.jchf.2013.11.004. PMC:3984539. PMID:24720917.
↑  Nieminen, M. S., Böhm, M., Cowie, M. R., Drexler, H., Filippatos, G. S., Jondeau, G., ... & Rhodes, A. (2005). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure. European heart journal, 26(4), 384-416.
1 2  Borlaug, B. A., Lam, C. S., Roger, V. L., Rodeheffer, R. J., & Redfield, M. M. (2009). Contractility and ventricular systolic stiffening in hypertensive heart disease: insights into the pathogenesis of heart failure with preserved ejection fraction. Journal of the American College of Cardiology, 54(5), 410-418.
↑  Segura, A. M., Frazier, O. H., & Buja, L. M. (2014). Fibrosis and heart failure. Heart failure reviews, 19(2), 173-185.
↑  Kong, P., Christia, P., & Frangogiannis, N. G. (2014). The pathogenesis of cardiac fibrosis. Cellular and Molecular Life Sciences, 71(4), 549-574.
↑  van Heerebeek, L., Borbély, A., Niessen, H. W., Bronzwaer, J. G., van der Velden, J., Stienen, G. J., ... & Paulus, W. J. (2006). Myocardial structure and function differ in systolic and diastolic heart failure. Circulation, 113(16), 1966-1973.
↑  Borbély, A., van der Velden, J., Papp, Z., Bronzwaer, J. G., Edes, I., Stienen, G. J., & Paulus, W. J. (2005). Cardiomyocyte stiffness in diastolic heart failure. Circulation, 111(6), 774-781.
↑  Aurigemma, G. P., & Gaasch, W. H. (2004). Diastolic heart failure. New England Journal of Medicine, 351(11), 1097-1105.
↑  Baicu, C. F., Zile, M. R., Aurigemma, G. P., & Gaasch, W. H. (2005). Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation, 111(18), 2306-2312.
↑  Oh, J. K., Hatle, L., Tajik, A. J., & Little, W. C. (2006). Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. Journal of the American College of Cardiology, 47(3), 500-506.
↑  Eric J. Topol؛ Robert M. Califf (2007). Textbook of cardiovascular medicine. Lippincott Williams & Wilkins. ص. 420–. ISBN:978-0-7817-7012-5. مؤرشف من الأصل في 2014-07-08. اطلع عليه بتاريخ 2010-11-16.
↑  Bhella PS، Hastings JL، Fujimoto N، Shibata S، Carrick-Ranson G، Palmer MD، Boyd KN، Adams-Huet B، Levine BD (2014). "Impact of lifelong exercise "dose" on left ventricular compliance and distensibility". Journal of the American College of Cardiology. ج. 64 ع. 12: 1257–1266. DOI:10.1016/j.jacc.2014.03.062. PMC:4272199. PMID:25236519. مؤرشف من الأصل في 2019-12-12.
↑  Crowley، Leonard V. (2013). An Introduction to Human Disease: Pathology and Pathophysiology Correlations. Jones & Bartlett Publishers. ص. 323. ISBN:9781449632403. مؤرشف من الأصل في 2019-12-17. اطلع عليه بتاريخ 2014-08-16. In this condition, called diastolic heart failure, the volume of blood contained in the ventricles during diastole is lower than it should be, and the pressure of the blood within the chambers is elevated.
↑  Estafanous 2001.
↑  Kawaguchi, M., Hay, I., Fetics, B., & Kass, D. A. (2003). Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction. Circulation, 107(5), 714-720.
↑  Yip, G., Wang, M., Zhang, Y., Fung, J. W. H., Ho, P. Y., & Sanderson, J. E. (2002). Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition?. Heart, 87(2), 121-125.
↑  Borlaug, B. A., Kane, G. C., Melenovsky, V., & Olson, T. P. (2016). Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. European heart journal, ehw241.
↑  Lam, C. S., Roger, V. L., Rodeheffer, R. J., Borlaug, B. A., Enders, F. T., & Redfield, M. M. (2009). Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. Journal of the American College of Cardiology, 53(13), 1119-1126.
↑  Dixon, D. D., Trivedi, A., & Shah, S. J. (2016). Combined post-and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction. Heart failure reviews, 21(3), 285-297.
↑  Gorter, T. M., Hoendermis, E. S., van Veldhuisen, D. J., Voors, A. A., Lam, C. S., Geelhoed, B., ... & van Melle, J. P. (2016). Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta‐analysis. European journal of heart failure, 18(12), 1472-1487.
↑  Borlaug, B. A., Olson, T. P., Lam, C. S., Flood, K. S., Lerman, A., Johnson, B. D., & Redfield, M. M. (2010). Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. Journal of the American College of Cardiology, 56(11), 845-854.
↑  Abudiab, Muaz M., et al. "Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction." European journal of heart failure 15.7 (2013): 776-785.
↑  Yu, C. M., Zhang, Q., Yip, G. W., Lee, P. W., Kum, L. C., Lam, Y. Y., & Fung, J. W. H. (2007). Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition. Journal of the American College of Cardiology, 49(1), 97-105.
↑  Haykowsky, M. J., Brubaker, P. H., Stewart, K. P., Morgan, T. M., Eggebeen, J., & Kitzman, D. W. (2012). Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. Journal of the American College of Cardiology, 60(2), 120-128.
↑  Erdei T، Aakhus S، Marino P، Paulus WJ، Smiseth OA، Fraser AG (2015). "Pathophysiological rationale and diagnostic targets for diastolic stress testing". المُهجة. ج. 101 ع. 17: 1355–60. DOI:10.1136/heartjnl-2014-307040. PMID:26001845.
↑  Borlaug, B. A., Kane, G. C., Melenovsky, V., & Olson, T. P. (2016). Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. European heart journal, ehw241.
↑  Dhakal, B. P., Malhotra, R., Murphy, R. M., Pappagianopoulos, P. P., Baggish, A. L., Weiner, R. B., ... & Lewis, G. D. (2015). Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection FractionCLINICAL PERSPECTIVE. Circulation: Heart Failure, 8(2), 286-294.
↑  Zheng، Sean Lee؛ Chan، Fiona T؛ Nabeebaccus، Adam A؛ Shah، Ajay M؛ McDonagh، Theresa؛ Okonko، Darlington O؛ Ayis، Salma (مارس 2018). "Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis". Heart. ج. 104 ع. 5: 407–415. DOI:10.1136/heartjnl-2017-311652. PMID:28780577. مؤرشف من الأصل في 2019-06-02.
↑  Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR, Kjeldsen K, Jankowska EA, Atar D, Butler J, Fiuzat M, Zannad F, Pitt B, O'Connor CM. J Am Coll Cardiol. 2014 Dec;64(21):2281-93. Epub 2014 Nov 24.
1 2  Zheng، Sean Lee؛ Chan، Fiona T؛ Nabeebaccus، Adam A؛ Shah، Ajay M؛ McDonagh، Theresa؛ Okonko، Darlington O؛ Ayis، Salma (مارس 2018). "Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis". Heart. ج. 104 ع. 5: 407–415. DOI:10.1136/heartjnl-2017-311652. مؤرشف من الأصل في 2019-06-02.
↑  Iwano، H؛ Little، WC (يوليو 2013). "Heart failure: what does ejection fraction have to do with it?". Journal of Cardiology (Review). ج. 62 ع. 1: 1–3. DOI:10.1016/j.jjcc.2013.02.017. PMID:23672790. مؤرشف من الأصل في 2019-12-17.
↑  Nanayakkara، S؛ Kaye، DM (أكتوبر 2015). "Management of heart failure with preserved ejection fraction: a review". Clinical Therapeutics (Review). ج. 37 ع. 10: 2186–2198. DOI:10.1016/j.clinthera.2015.08.005. PMID:26385583.
↑  Gielen، S؛ Laughlin، MH؛ O'Conner، C؛ Duncker، DJ (يناير–فبراير 2015). "Exercise training in patients with heart disease: review of beneficial effects and clinical recommendations". Progress in Cardiovascular Diseases (Review). ج. 57 ع. 4: 347–55. DOI:10.1016/j.pcad.2014.10.001. PMID:25459973.
↑  Hummel, S. L., Seymour, E. M., Brook, R. D., Kolias, T. J., Sheth, S. S., Rosenblum, H. R., ... & Weder, A. B. (2012). Low-Sodium Dietary Approaches to Stop Hypertension Diet Reduces Blood Pressure, Arterial Stiffness, and Oxidative Stress in Hypertensive Heart Failure With Preserved Ejection FractionNovelty and Significance. Hypertension, 60(5), 1200-1206.
↑  Yancy، CW؛ Jessup، M؛ Bozkurt، B؛ Butler، J؛ Casey Jr، DE؛ Drazner، MH؛ Fonarow، GC (أكتوبر 2013). "2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines". Journal of the American College of Cardiology (Review). ج. 62 ع. 16: e147-239. DOI:10.1016/j.jacc.2013.05.019. PMID:23747642. مؤرشف من الأصل في 2019-12-05.
↑  Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. Schwartzenberg S, Redfield MM, From AM, Sorajja P, Nishimura RA, Borlaug BA. J Am Coll Cardiol. 2012 Jan;59(5):442-51.
↑  Zheng، Sean Lee؛ Chan، Fiona T؛ Nabeebaccus، Adam A؛ Shah، Ajay M؛ McDonagh، Theresa؛ Okonko، Darlington O؛ Ayis، Salma (مارس 2018). "Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis". Heart. ج. 104 ع. 5: 407–415. DOI:10.1136/heartjnl-2017-311652.
↑  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Flather MD, Shibata MC, Coats AJ, Van Veldhuisen DJ, Parkhomenko A, Borbola J, Cohen-Solal A, Dumitrascu D, Ferrari R, Lechat P, Soler-Soler J, Tavazzi L, Spinarova L, Toman J, Böhm M, Anker SD, Thompson SG, Poole-Wilson PA, SENIORS Investigators . Eur Heart J. 2005;26(3):215.
↑  Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Borlaug BA, Melenovsky V, Russell SD, Kessler K, Pacak K, Becker LC, Kass DA. Circulation. 2006 Nov;114(20):2138-47. Epub 2006 Nov 6.
↑  Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Aronow WS, Kronzon I. Am J Cardiol. 1993;71(7):602.
↑  A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE . Am J Med. 2003;115(1):41.
↑  Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Solomon SD, Janardhanan R, Verma A, Bourgoun M, Daley WL, Purkayastha D, Lacourcière Y, Hippler SE, Fields H, Naqvi TZ, Mulvagh SL, Arnold JM, Thomas JD, Zile MR, Aurigemma GP, Valsartan In Diastolic Dysfunction (VALIDD) Investigators. Lancet. 2007;369(9579):2079.
↑  Israel's CorAssist Keeps A Weak Heart Pumping نسخة محفوظة 03 يناير 2009 على موقع واي باك مشين.
↑  Trends in prevalence and outcome of heart failure with preserved ejection fraction. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. N Engl J Med. 2006;355(3):251.
↑  Outcome of heart failure with preserved ejection fraction in a population-based study. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP. N Engl J Med. 2006;355(3):260.
↑  How do patients with heart failure with preserved ejection fraction die? Chan MM, Lam CS. Eur J Heart Fail. 2013 Jun;15(6):604-13. Epub 2013 Apr 21.
↑  "Trends in prevalence and outcome of heart failure with preserved ejection fraction". N. Engl. J. Med. ج. 355 ع. 3: 251–59. يوليو 2006. DOI:10.1056/NEJMoa052256. PMID:16855265. مؤرشف من الأصل في 2009-08-05.
↑  "Outcome of heart failure with preserved ejection fraction in a population-based study". N. Engl. J. Med. ج. 355 ع. 3: 260–69. يوليو 2006. DOI:10.1056/NEJMoa051530. PMID:16855266. مؤرشف من الأصل في 2009-07-26.